Filter
637
Text search:
Diagnostics
and
Laboratory
Technology
Featured
81
168
Language
Document type
286
147
87
57
39
8
5
4
2
1
1
Countries / Regions
37
34
24
16
13
12
11
11
11
9
9
8
8
8
8
8
7
7
7
6
5
4
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
205
63
39
36
21
10
5
Toolboxes
125
63
54
42
37
17
17
14
13
13
13
10
10
8
8
6
5
5
4
3
3
3
1
Washington, D.C., USA, 23-27 September 2018
Provisional Agenda Item 4.6
CD56/10, Rev. 1 31 August 2018
Original: Spanish
Towards the Peoples Health Assembly Book - 1
Towards the Peoples Health Assembly Book -1
30 October 2017
Updated Treatment Guidelines
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Identified through evaluation of the response to pandemic (H1N1) 2009
